Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability

被引:29
作者
Kim, Yuhree [1 ]
Margonis, Georgios A. [1 ]
Prescott, Jason D. [1 ]
Tran, Thuy B. [2 ]
Postlewait, Lauren M. [3 ]
Maithel, Shishir K. [3 ]
Wang, Tracy S. [4 ]
Glenn, Jason A. [4 ]
Hatzaras, Ioannis [5 ]
Shenoy, Rivfka [5 ]
Phay, John E. [6 ]
Keplinger, Kara [6 ]
Fields, Ryan C. [7 ]
Jin, Linda X. [7 ]
Weber, Sharon M. [8 ]
Salem, Ahmed [8 ]
Sicklick, Jason K. [9 ]
Gad, Shady [9 ]
Yopp, Adam C. [10 ]
Mansour, John C. [10 ]
Duh, Quan-Yang [11 ]
Seiser, Natalie [11 ]
Solorzano, Carmen C. [12 ]
Kiernan, Colleen M. [12 ]
Votanopoulos, Konstantinos I. [13 ]
Levine, Edward A. [13 ]
Poultsides, George A. [2 ]
Pawlik, Timothy M. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[2] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA
[3] Emory Univ, Dept Surg, Atlanta, GA 30322 USA
[4] Med Coll Wisconsin, Dept Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA
[5] NYU, Dept Surg, Sch Med, New York, NY 10016 USA
[6] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[7] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[8] Univ Wisconsin, Sch Med & Publ Hlth, Dept Gen Surg, Madison, WI USA
[9] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA
[10] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX USA
[11] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
[12] Vanderbilt Univ, Dept Surg, Nashville, TN 37240 USA
[13] Wake Forest Sch Med, Dept Surg, Winston Salem, NC USA
关键词
adrenocortical carcinoma; conditional probability; outcomes; surgery; PROGNOSTIC-FACTORS; MULTIINSTITUTIONAL ANALYSIS; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; UNITED-STATES; FREE SURVIVAL; MITOTANE; FEATURES; TUMORS; ASSOCIATION;
D O I
10.1097/SLA.0000000000001527
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To evaluate conditional disease-free survival (CDFS) for patients who underwent curative intent surgery for adrenocortical carcinoma (ACC). Background: ACC is a rare but aggressive tumor. Survival estimates are usually reported as survival from the time of surgery. CDFS estimates may be more clinically relevant by accounting for the changing likelihood of disease-free survival (DFS) according to time elapsed after surgery. Methods: CDFS was assessed using a multi-institutional cohort of patients. Cox proportional hazards models were used to evaluate factors associated with DFS. Three-year CDFS (CDFS3) estimates at "x" year after surgery were calculated as follows: CDFS3 = DFS(x+3)/DFS(x). Results: One hundred ninety-two patients were included in the study cohort; median patient age was 52 years. On presentation, 36% of patients had a functional tumor and median size was 11.5 cm. Most patients underwent R0 resection (75%) and 9% had N1 disease. Overall 1-, 3-, and 5-year DFS was 59%, 34%, and 22%, respectively. Using CDFS estimates, the probability of remaining disease free for an additional 3 years given that the patient had survived without disease at 1, 3, and 5 years, was 43%, 53%, and 70%, respectively. Patients with less favorable prognosis at baseline demonstrated the greatest increase in CDFS3 over time (eg, capsular invasion: 28%-88%, Delta 60% vs no capsular invasion: 51%-87%, Delta 36%). Conclusions: DFS estimates for patients with ACC improved dramatically over time, in particular among patients with initial worse prognoses. CDFS estimates may provide more clinically relevant information about the changing likelihood of DFS over time.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 44 条
[1]   Clinical and biological features in the prognosis of adrenocortical cancer: Poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients [J].
Abiven, Gwenaelle ;
Coste, Joel ;
Groussin, Lionel ;
Anract, Philippe ;
Tissier, Frederique ;
Legmann, Paul ;
Dousset, Bertrand ;
Bertagna, Xavier ;
Bertherat, Jerome .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07) :2650-2655
[2]   A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease [J].
Asare, Elliot A. ;
Wang, Tracy S. ;
Winchester, David P. ;
Mallin, Katherine ;
Kebebew, Electron ;
Sturgeon, Cord .
SURGERY, 2014, 156 (06) :1378-1386
[3]   Conditional Survival in Patients with Thyroid Cancer [J].
Banerjee, Mousumi ;
Muenz, Daniel G. ;
Worden, Francis P. ;
Wong, Sandra L. ;
Haymart, Megan R. .
THYROID, 2014, 24 (12) :1784-1789
[4]   Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial [J].
Berruti, A ;
Terzolo, M ;
Sperone, P ;
Pia, A ;
Della Casa, S ;
Gross, DJ ;
Carnaghi, C ;
Casali, P ;
Porpiglia, F ;
Mantero, F ;
Reimondo, G ;
Angeli, A ;
Dogliotti, L .
ENDOCRINE-RELATED CANCER, 2005, 12 (03) :657-666
[5]   Adrenocortical Carcinoma in the United States Treatment Utilization and Prognostic Factors [J].
Bilimoria, Karl Y. ;
Shen, Wen T. ;
Elaraj, Dina ;
Bentrern, David J. ;
Winchester, David J. ;
Kebebew, Electron ;
Sturgeon, Cord .
CANCER, 2008, 113 (11) :3130-3136
[6]   Conditional Disease-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors A Multi-institutional Analysis of 502 Patients [J].
Bischof, Danielle A. ;
Kim, Yuhree ;
Dodson, Rebecca ;
Jimenez, M. Carolina ;
Behman, Ramy ;
Cocieru, Andrei ;
Fisher, Sarah B. ;
Groeschl, Ryan T. ;
Squires, Malcolm H., III ;
Maithel, Shishir K. ;
Blazer, Dan G., III ;
Kooby, David A. ;
Gamblin, T. Clark ;
Bauer, Todd W. ;
Quereshy, Fayez A. ;
Karanicolas, Paul J. ;
Law, Calvin H. L. ;
Pawlik, Timothy M. .
JAMA SURGERY, 2015, 150 (04) :299-306
[7]   INDEXES AND BOUNDARIES FOR QUANTITATIVE SIGNIFICANCE IN STATISTICAL DECISIONS [J].
BURNAND, B ;
KERNAN, WN ;
FEINSTEIN, AR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (12) :1273-1284
[8]  
Canter DJ, 2013, CAN J UROL, V20, P6915
[9]   Adrenocortical carcinoma: which surgical approach? [J].
Carnaille, Bruno .
LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (02) :195-199
[10]   Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients [J].
Cucchetti, Alessandro ;
Piscaglia, Fabio ;
Cescon, Matteo ;
Ercolani, Giorgio ;
Terzi, Eleonora ;
Bolondi, Luigi ;
Zanello, Matteo ;
Pinna, Antonio D. .
CLINICAL CANCER RESEARCH, 2012, 18 (16) :4397-4405